title: Is Neoadjuvant Radiotherapy Alone a Good Alternative to Neoadjuvant Chemoradiotherapy in Patients with Low Performance Status?
authors.forename: Cemil
authors.initials: C
authors.lastname: Caliskan
authors.forename: Tayfun
authors.initials: T
authors.lastname: Yoldas
authors.forename: Kilongo
authors.initials: K
authors.lastname: Mulailwa
authors.forename: Kamil
authors.initials: K
authors.lastname: Erozkan
authors.forename: Deniz
authors.initials: D
authors.lastname: Yalman
authors.forename: Serdar
authors.initials: S
authors.lastname: Ozkok
authors.forename: Erhan
authors.initials: E
authors.lastname: Akgun
authors.forename: Mustafa
authors.initials: M
authors.lastname: Korkut
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D059186:Chemoradiotherapy, Adjuvant; D004307:Dose-Response Relationship, Radiation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D000072078:Positron Emission Tomography Computed Tomography; D012004:Rectal Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000532:radiotherapy*; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents